Cardinal Health Investor Day to Highlight Long-Term Value Creation
Cardinal Health (NYSE: CAH) today will host an Investor Day beginning at 9:00 a.m. ET, where among other updates, management will detail its growth strategies to maximize the company’s potential for all stakeholders and move healthcare forward. “We are excited to…
Cardinal Health announces the merger of its Outcomes™ business into Transaction Data Systems and related partnership
Cardinal Health today announced it has signed a definitive agreement to contribute its Outcomes™ business to Transaction Data Systems (TDS), a portfolio company of BlackRock Long Term Private Capital and GTCR, in exchange for a minority stake in the combined entity. Under…
Cardinal Health launches Modern Commerce Solutions for Retail Independent Pharmacies powered by Square
Cardinal Health (NYSE: CAH) today launched modern payment solutions, powered by Square, to help independent pharmacies increase operational efficiency, stay current with customer payment preferences, and access integrated software tools for their business. The collaboration with Square allows Cardinal Health to offer its…
Pfizer Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B Trial
Today announced that the pivotal Phase 3 BASIS clinical trial (NCT03938792) evaluating marstacimab has met its primary endpoints, having demonstrated statically significant and clinically meaningful effects. Marstacimab, a novel, investigational anti-tissue factor pathway inhibitor (anti-TFPI) being studied for the treatment…
U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO™ (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, for the prevention of lower respiratory tract disease caused by RSV…
Phase 3 Studies of Pfizer’s Novel Antibiotic Combination Offer New Treatment Hope for Patients with Multidrug-Resistant Infections and Limited Treatment Options
fizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 program comprising the REVISIT (NCT03329092) and ASSEMBLE (NCT03580044) studies evaluating the efficacy, safety, and tolerability of the novel investigational antibiotic combination aztreonam-avibactam (ATM-AVI) in treating serious bacterial infections…
Spotless Brands Names John Standley as CEO to Propel Bold Plans Forward
Spotless Brands, a leading car wash platform in the United States, appoints highly respected retail executive, John Standley, as the company’s new CEO to accelerate the company’s growth and cement its position as the leading operator in every market served.…
PropTech Company, Doormat, Raises $1.25 Million in Pre-Seed Funding, Revolutionizing a Critical Stage of the Homeownership Journey
Today, Doormat, Ontario’s real estate lawyer, enhancing the client experience and streamlining the legal process with advanced technology solutions, has announced it has raised $1.25M in pre-seed funding. Through this, Doormat is bringing much-needed simplicity and ease to the real estate…
Personal Financial Management Becomes New Frontier for Bank and Credit Card Apps, J.D. Power Finds
After more than a decade of significant investment in mobile apps and websites, many U.S. banks and credit card providers have mastered the basics of digital transaction management and are now turning their attention to more advanced “super tools.” According…
Modivcare Releases 2022 Environmental, Social, and Governance Report Highlighting Commitment to Eliminating Inequities in Healthcare and Enhancing Sustainability Efforts
Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company released its 2022 Environmental, Social, and Governance (ESG)…
Global Health Study Validates Biospectal OptiBP Mobile Blood Pressure Measurement App Accuracy Across Diverse Settings
Biospectal SA, the remote patient monitoring and biosensing software company, today announced the publication of global health study results published in Nature’s NPJ Digital Medicine of the first independent research and validation study to use Biospectal’s mobile blood pressure monitoring app, OptiBP™…
Covalon Announces Second Quarter Results for Fiscal 2023
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its second quarter fiscal 2023 results. “I am pleased to announce another strong financial quarter for Covalon. Revenue for the three months…